Rx Minute Newsletter

Rx Minute is a PhRMA newsletter that aims to keep policymakers and the public up-to-date on recently published studies on issues that affect the discovery, use, impact and coverage of medicines. Each monthly issue includes straightforward summaries on recent, notable studies or reports on a wide-range of policy-related topics.

December 2012

Statins Value to Society & Risk Factors Linked to Alzheimer's

Archived Newsletters

• Offsets in Heart Failure Treatment & Seniors Selecting Lower Costs Part D Plans
• Insurance for Chronically Ill & A Look at Orphan Drugs
• Medicare Part D Reduces Nondrug Medical Spending & Economic Contributions of the Biopharma Sector
• The Problem of Cancer Drug Abandonment & Preventing HIV Transmission
• Adherence to Medicines Reduces Overall Health Care Costs
• Biopharmaceutical companies embracing personalized medicine & Major advances in cancer medicines in 2010
• A New Treatment Approach to Hodgkin’s Lymphoma Shows Promise & Medicare Prescription Drug Plan Increased Liklihood of Heart Failure Patients Taking Medicines
• Alzheimer’s Burden Will Balloon if New Treatments Are Not Found & Complexity and Execution Burden of Clinical Trials Are Rising
• Cancer treatments have created nearly $2 trillion in societal value & Major advances in cancer medicines in 2009
• Sustaining Biologics R&D; Potential Impact of FOB Legislation & Cost of Medicare Drug Coverage Substantially Offset by Lower Overall Spending
• Early HIV Treatment May Improve Survival & Bone loss drug may help breast cancer patients
• Higher Copays Slow Start of Treatment for Patients with Chronic Conditions & Statins help reduce the risk of stroke